Get the Stockscreener App
1.73
1.17%
0.02
After Hours:
1.70
-0.03
-1.73%
Essa Pharma Inc Stock (EPIX) Latest News
Class Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for Investors – Contact Levi & Korsinsky - GlobeNewswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your RightsEPIX - PR Newswire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
EPIX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit - PR Newswire
ESSA ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
EPIX Investor Notice: Shareholder Rights Law Firm Robbins - GlobeNewswire
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Malaysian Reserve
Stockholder Alert: Robbins LLP Informs Investors of the ESS Pharma Inc. Class Action - cnhinews.com
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
ESSA Pharma Misled Investors Over Cancer Treatment, Lawsuit Says - Bloomberg Law
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against ESSA Pharma Inc. (EPIX) - EIN News
Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire
Short Interest in ESSA Pharma Inc. (NASDAQ:EPIX) Declines By 5.3% - MarketBeat
ESSA Pharma (NASDAQ:EPIX) Share Price Passes Below 50 Day Moving AverageTime to Sell? - MarketBeat
3 Promising US Penny Stocks With Market Caps Under $80M - Simply Wall St
ESSA Pharma Inc. (NASDAQ:EPIX) Sees Significant Growth in Short Interest - MarketBeat
ESSA Pharma (NASDAQ:EPIX) Stock Price Passes Below 50 Day Moving Average – What’s Next? - Defense World
ESSA Pharma (NASDAQ:EPIX) Stock Price Passes Below 50 Day Moving AverageWhat's Next? - MarketBeat
Surprising News! ESSA Pharma’s Big Breakthrough Expected Soon. - Jomfruland.net
When Will ESSA Pharma Inc. (NASDAQ:EPIX) Turn A Profit? - Yahoo Finance
ESSA Pharma’s Cash Management: A Potential Risk to Shareholder Value and Market Stability - TipRanks
ESSA Pharma Inc. Reports Strategic Shift Amid Losses - TipRanks
ESSA Pharma: Fiscal Q4 Earnings Snapshot - The Ridgefield Press
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 - Barchart
ESSA Pharma Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024 - Marketscreener.com
ESSA Pharma (NASDAQ:EPIX) Issues Earnings Results - MarketBeat
SEC Form 10-K filed by ESSA Pharma Inc. - Quantisnow
ESSA Pharma Halts Key Cancer Drug Trials, Initiates Strategic Review Amid Clinical Setback - StockTitan
ESSA Pharma ends long-standing license agreement with cancer agencies - Investing.com
ESSA Pharma Inc. Adopts Executive Severance Plan**United States Securities and Exchange Commission Filing – ESSA Pharma Inc. submitted a current report on Form 8-K, dated June 5, 2024, announcing the adoption of the ESSA Pharma Inc. Severance P - Defense World
ESSA Pharma Introduces New Executive Severance Plan - TipRanks
RTW Investments LP Grows Stake in ESSA Pharma Inc. (NASDAQ:EPIX) - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc.EPIX - PR Newswire
Applied Digital, ESSA Pharma And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session - MSN
Piper Sandler Downgrades ESSA Pharma (EPIX) - MSN
United States shares higher at close of trade; Dow Jones Industrial Average up 0.69% - MSN
Thinking about buying stock in Adverum Biotechnologies, Roma Gre - GuruFocus.com
Oppenheimer Downgrades ESSA Pharma (EPIX) - MSN
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):